‘Lack of controls’: Are GLP-1s being prescribed to vulnerable patients?

Reports of GLP-1s being prescribed to vulnerable Australians have alarmed eating disorder support organisations, but regulators say there is no rise in associated cases The national medicines regulator says it is aware of some cases of Glucagon-like peptide-1 (GLP-1) receptor agonists being prescribed to vulnerable Australians, with a handful of reports in the past few